Table 2.
Human (Homo sapiens) and horse (Equus caballus) α-synuclein (α-syn) amino acid sequences. The 140 amino acid α-syn protein consists of three regions: N-terminal amphipathic region (residues 1 to 60), hydrophobic non-amyloid-β component (NAC) (residues 61–95) and the acidic C-terminal region (residues 96–140). Tango bioinformatic aggregation scores (35–37) of the full-length human and equine α-syn are 896 and 1042, respectively. Aggregation scores for each segment of the human and equine α-syn.
| Fragment | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | Variation | Agg score |
| Human | M | D | V | F | M | K | G | L | S | K | A | K | E | G | V | V | A | A | A | E | K | T | K | Q | G | 57 | |
| Horse | M | D | V | F | M | K | G | L | S | K | A | K | E | G | V | V | A | A | A | E | K | T | K | Q | G | 0 | 57 |
| Fragment | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | ||
| Human | V | A | E | A | A | G | K | T | K | E | G | V | L | Y | V | G | S | K | T | K | E | G | V | V | H | 291 | |
| Horse | V | A | E | A | A | G | K | T | K | E | G | V | L | Y | V | G | S | K | T | K | E | G | V | V | H | 0 | 291 |
| Fragment | 51 | 52 | 53 | 54 | 55 | 56 | 57 | 58 | 59 | 60 | 61 | 62 | 63 | 64 | 65 | 66 | 67 | 68 | 69 | 70 | 71 | 72 | 73 | 74 | 75 | ||
| Human | G | V | A | T | V | A | E | K | T | K | E | Q | V | T | N | V | G | G | A | V | V | T | G | V | T | 117 | |
| Horse | G | V | T | T | V | A | E | K | T | K | E | Q | V | T | N | V | G | E | A | V | V | T | G | V | T | 2 | 56 |
| Fragment | 76 | 77 | 78 | 79 | 80 | 81 | 82 | 83 | 84 | 85 | 86 | 87 | 88 | 89 | 90 | 91 | 92 | 93 | 94 | 95 | 96 | 97 | 98 | 99 | 100 | ||
| Human | A | V | A | Q | K | T | V | E | G | A | G | S | I | A | A | A | T | G | F | V | K | K | D | Q | L | 5 | |
| Horse | A | V | A | Q | K | T | V | E | G | A | E | S | I | A | A | A | T | G | F | G | K | K | D | H | L | 3 | 8 |
| Fragment | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 | 56 | 57 | 58 | 59 | 60 | 61 | ||
| Human | V | L | Y | V | G | S | K | T | K | E | G | V | V | H | G | V | A | T | V | A | E | K | T | K | E | 53 | |
| Horse | V | L | Y | V | G | S | K | T | K | E | G | V | V | H | G | V | T | T | V | A | E | K | T | K | E | 1 | 39 |
| Fragment | 62 | 63 | 64 | 65 | 66 | 67 | 68 | 69 | 70 | 71 | 72 | 73 | 74 | 75 | 76 | 77 | 78 | 79 | 80 | 81 | 82 | 83 | 84 | 85 | 86 | ||
| Human | Q | V | T | N | V | G | G | A | V | V | T | G | V | T | A | V | A | Q | K | T | V | E | G | A | G | 483 | |
| Horse | Q | V | T | N | V | G | E | A | V | V | T | G | V | T | A | V | A | Q | K | T | V | E | G | A | E | 2 | 637 |
| Fragment | 91 | 92 | 93 | 94 | 95 | 96 | 97 | 98 | 99 | 100 | 101 | 102 | 103 | 104 | 105 | 106 | 107 | 108 | 109 | 110 | 111 | 112 | 113 | 114 | 115 | ||
| Human | A | T | G | F | V | K | K | D | Q | L | G | K | N | E | E | G | A | P | Q | E | G | I | L | E | D | 0 | |
| Horse | A | T | G | F | G | K | K | D | H | L | G | K | S | E | E | G | A | A | Q | E | G | I | L | E | D | 4 | 0 |
| Fragment | 116 | 117 | 118 | 119 | 120 | 121 | 122 | 123 | 124 | 125 | 126 | 127 | 128 | 129 | 130 | 131 | 132 | 133 | 134 | 135 | 136 | 137 | 138 | 139 | 140 | ||
| Human | M | P | V | D | P | D | N | E | A | Y | E | M | P | S | E | E | G | Y | Q | D | Y | E | P | E | A | 0 | |
| Horse | M | P | V | D | P | D | N | E | A | Y | E | M | P | S | E | E | G | Y | Q | D | Y | E | P | E | A | 0 | 0 |
Peptide are provided in the right-sided column.